Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenues
Octapharma Announces Availability of Balfaxar® For Warfarin Reversal in Urgent Surgery & Invasive Procedures
4DMT and Arbor Biotechnologies Establish Partnership to Co-Develop and Co-Commercialize Next-Generation Genetic Medicines for CNS Diseases
On Target Laboratories Names Scott Huennekens as Executive Chairperson of the Board
4DMT and Arbor Biotechnologies Establish Partnership to Co-Develop and Co-Commercialize Next-Generation Genetic Medicines for CNS Diseases
Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering
Processa Pharmaceuticals to Present at the Biotech Showcase 2024
Specialty Pharmaceutical Market Projected to Exceed USD 1532.8 Billion by 2033; Amid Rising Popularity of Advanced Therapeutics and Personalized Medicine
FDA Roundup: January 2, 2024
Theratechnologies Submits sBLA for Trogarzo® Intramuscular (IM) Method of Administration to FDA
 2   3   4   5   6     7    8   9   10   11   12 
 <<   <   >   >>